Download presentation
Presentation is loading. Please wait.
Published byDebra Skinner Modified over 8 years ago
1
A LEGAL UPDATE By: Ben Hemmelgarn
2
Introduction Personal Introduction Coordination with Governments Convention on Biological Diversity Nagoya Protocol Access and Benefit Sharing DNA Import/Export Future Intellectual Property Issues Future Genetic Privacy Issues
3
Personal Introduction
4
Convention on Biological Diversity Earth Day in Rio de Janeiro Effective December 29, 1993 196 Parties Help develop national strategies for conservation and sustainable use of biological diversity
5
Convention on Biological Diversity Cartagena Protocol on Biosafety Effective September 11, 2003 170 Parties Primarily focused on safe handling, transport, and use of living modified organisms. Nagoya Protocol Effective October 12, 2014 73 Parties Implementation of CBD goal for fair and equitable sharing of benefits from genetic resources.
6
Nagoya Protocol Croatia Egypt European Union Germany India Mexico Norway South Africa Spain Switzerland United Kingdom Uruguay MetaSUB countries that are a party to the Nagoya Protocol
7
Nagoya Protocol Access Prior Informed Consent From a Competent National Authority Benefit Sharing Utilization of Genetic Resources Includes research and development Includes subsequent commercialization Benefits can be Monetary Non-Monetary Training Sharing results
8
ABS Clearing House
9
County Profiles
10
MetaSUB and Access Different regimes encountered No Prior Informed Consent (PIC) required. Portugal, Germany, Norway, UK, Sweden PIC from transit authority New Zealand, Japan PIC from state-level government Colombia, Australia PIC from national government (environmental agency) Brasil, Argentina, Singapore, Italy, India, Qatar
11
MetaSUB and Benefit Sharing Model Agreement (MetroRio in Rio de Janeiro) Public Domain Proprietary
12
DNA Export Laws Prohibited Goods Not allowed to leave the country Restricted Goods Exportation is regulated South Africa Example DNA is regulated under the Non-Proliferation of Weapons of Mass Destruction Act 87 of 1993 Need to Contact the Non-Proliferation Office Need to fill out a Material Safety Data Sheet
13
DNA Export Laws Material Safety Data Sheet Isolated DNA in suspension DNA Swabs
14
Future Intellectual Property Issues Synthesis from DNA collected Small molecules Drugs Full organisms Data sharing Subsequent negotiations with provider states
15
Future Genetic Privacy Issues Reasonable Expectation of Privacy
16
Questions Contact Info Ben Hemmelgarn Hemmelgarn.58@gmail.com +1-513-668-5643
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.